USPTO serial 79307220
ARVIDAL
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- PIERCE, ALEXANDRA
- Law office
- TTAB
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ARVIDAL?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
MATTHEW A HOMYK
MATTHEW A HOMYK BLANK ROME LLPONE LOGAN SQUAREPHILADELPHIA, PA 19103UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections or diseases caused by viruses, namely, by intravenous, intramuscular, oral, sublingual, buccal, nasal, topical administration and/or administered by inhalation, by spraying or by nebulisation in patients; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viruses, seasonal and pandemic influenza A and B viruses, seasonal coronaviruses being Alpha-, Beta-, Gamma- and Deltacoronaviruses, severe acute respiratory syndrome (SARS-CoV) coronaviruses and Middle East respiratory syndrome (MERS) coronavirus, adenoviruses, respiratory syncytial viruses, parainfluenza viruses, rhinoviruses, human metapneumoviruses, bocaviruses, and infections of combined etiology being multiple viral infections; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention, and treatment of acute respiratory infections caused by viral infections of the upper and lower respiratory tract; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of tissue lesions in the lungs caused by severe pulmonary infectious diseases; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of complications arising from or caused by viral infections; pharmaceutical preparations and pharmaceutical products for the prevention and treatment of acute respiratory infections, acute respiratory viral infections of unknown origins and complications arising from or caused by viral infections | ABANDONED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 5, 2023 | FINT | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Mar 14, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Mar 14, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Oct 31, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Oct 12, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 12, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Mar 15, 2022 | MAB4 | ABANDONMENT NOTICE E-MAILED - INTER PARTES DECISION | — |
| Mar 14, 2022 | ABN4 | ABANDONMENT - AFTER INTER PARTES DECISION | — |
| Mar 14, 2022 | OP.T | OPPOSITION TERMINATED NO. 999999 | — |
| Mar 14, 2022 | OP.S | OPPOSITION SUSTAINED NO. 999999 | — |
| Dec 13, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Nov 22, 2021 | OP.I | OPPOSITION INSTITUTED NO. 999999 | — |
| Nov 16, 2021 | OPNS | OPPOSITION NOTICE (IB REFUSAL) SENT TO IB | — |
| Nov 16, 2021 | OPNC | OPPOSITION NOTICE (IB REFUSAL) CREATED | — |
| Nov 15, 2021 | OPPF | OPPOSITION PAPERS RECEIVED AT TTAB | — |
| Nov 2, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 2, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 13, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 28, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 27, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 27, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 27, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 24, 2021 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 2, 2021 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 2, 2021 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Jul 2, 2021 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 1, 2021 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jun 24, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 4, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 3, 2021 | DOCK | ASSIGNED TO EXAMINER | — |
| May 13, 2021 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| May 10, 2021 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| Apr 2, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Mar 29, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Mar 25, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |